Literature Search That Turns Science Into Safety Intelligence
Literature Surveillance That Keeps You Aligned with Global Safety Requirements
Monitoring scientific literature is a critical responsibility in pharmacovigilance and regulatory compliance. APCER Life Sciences supports organizations in navigating this responsibility with structured literature surveillance services designed to identify, review, and interpret relevant safety information across the entire product lifecycle, augmented by proprietary technology.
Whether your product is in clinical development, approaching authorization, or already in the market, our teams ensure that literature monitoring is conducted with scientific rigor, regulatory awareness, and operational consistency.
Literature Surveillance Services
Our dedicated literature surveillance specialists combine scientific expertise with advanced database capabilities, leveraging proprietary AI powered ANSA PV LitSense technology to deliver comprehensive searches, in-depth reviews, and regulatory-aligned scientific assessments. From full text article review to country specific literature screening, APCER delivers reliable results through a structured and client focused approach.
Literature Search Expertise in Practice
Case Study
A specialty pharmaceutical company resolved literature surveillance gaps and improved inspection readiness through APCER's targeted risk-based review approach.
Case Study
APCER managed global and local literature surveillance activities, helping a leading device and pharmaceutical company maintain regulatory compliance worldwide.
Let’s Strengthen Your Literature Surveillance Program
Looking to enhance your pharmacovigilance capabilities with APCER’s literature surveillance expertise? Share your requirements with us and our team will connect with you to understand your needs and explore solutions tailored to support your regulatory and safety objectives.
Our Impact at a Glance
Literature Surveillance Expertise Amplified by Technology
APCER’s Literature Surveillance expertise is strengthened by a purpose built proprietary AI enabled tool - ANSA PV LitSense. This platform is designed to support end-to-end literature screening—from abstract review to full-text analysis and ICSR identification. Combining AI-driven literature screening with expert pharmacovigilance oversight, the platform enables consistent, traceable, and scalable drug safety literature monitoring aligned with global regulatory requirements.
- Accelerated Literature Screening AI-assisted abstract and full-text review to improve pharmacovigilance literature screening efficiency.
- Consistent Case Identification Configurable classification for accurate ICSR identification from global medical literature.
- End-to-End Traceability Audit-ready outputs supporting compliant pharmacovigilance literature monitoring.
- Expert-Led Review Human-in-the-loop validation ensuring scientific rigor and regulatory alignment.
Ready for a partner who matches your ambition?
With APCER, you gain more than a service provider—you secure a champion for compliance, a catalyst for growth, and a steadfast ally dedicated to protecting patients and your reputation.
Quality and Compliance
- Version-controlled SOPs
- Role-based structured training
- End-to-end Deviation and CAPA lifecycle management
- Risk-based audit program
- electronic Quality Management System (eQMS) and electronic Learning Management System (eLMS)
Real Results. Real Trust.
Real Stories
Sincerely thank you for all the effort, thoroughness and professionalism that went through conducting and reporting on this FDA PADER Gap Analysis as we now embark on our journey towards documentation and process improvement to ensure readiness for an actual inspection.
Director, Drug Safety and Medical Information
Canada-based global pharma
The APCER Pharmacovigilance team demonstrated exceptional collaboration and inspection readiness during FDA PADE Inspection. The accuracy, consistency, and completeness of expedited reports, reconciliations, and aggregate safety documentation clearly reflected strong teamwork and compliance across all deliverables.
VP, Regulatory and Quality
US-based biopharma
With all the transformation and rapid growth happening, having a reliable PV/med info partner like the APCER group has truly been invaluable—it’s made a real difference in helping us navigate the complexities and keep challenges to a minimum.
VP, Medical Affairs
US-based specialty pharma
... the preparation and support for our BPD Type 2a meeting were a strong example of APCER’s commitment and effectiveness and instrumental in keeping us aligned and confident in our regulatory strategy. We have greatly valued the team’s responsiveness, collaborative approach, and sound regulatory judgment.
Chief Medical Officer
A clinical-stage biopharma
Phase 1 completion is an achievement that demonstrates APCER's scalability, flexibility, and operational readiness. It reflects exceptional cross-functional collaboration.
Associate Director, IT Business Partner
Japan-headquartered, global healthcare company
I want to sincerely appreciate all the great work Team APCER has been doing. Their strong attention to detail, agility in handling tasks, and consistent respect for timelines have been truly impressive.
Associate Director, Safety Physician
Japan-headquartered, global healthcare company
Deep gratitude to entire APCER team for their efforts in working hard to complete the cases. While the system outage was well beyond their control, their strong work to make up for the lost time ensured that we're able to maintain compliance.
Associate Director, Pharmacovigilance Operations
US-based biotech
Sincere appreciation for APCER's partnership and dedicated service. The team’s commitment, adaptability, and collaborative approach have been instrumental in supporting our pharmacovigilance operations through both high and low volumes of activity.
Sr.Director, PV Operations-Global Case Management
US-based biotech
I’ve greatly valued APCER’s commitment to excellence. Their contributions have played a key role in helping us uphold our compliance standards and achieve strong performance across key metrics, including timely deviation closure, audit readiness, and quality of deliverables.
Sr. Director PV Ops – Pharmacovigilance Center of Excellence
US-based biotech
